Cytek Biosciences, Inc 10-Q for FY2021 Q3
Cytek Biosciences, Inc. (CTKB)
10-Q
2021-11-12
For: 2021-09-30
View Original
Added on
April 09, 2026
About this 10-Q
Cytek Biosciences, Inc filed this 10-Q on November 12, 2021, covering the quarter ended September 30, 2021 (FY2021 Q3).
Headline figures
Quarter ended September 30, 2021, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $34.38M
- up 37.0% from $25.1M a year earlier
- Net income
- $1.42M
- down 78.3% from net income of $6.54M a year earlier
- Diluted EPS
- $0.00
- down 93.4% from $0.05 a year earlier